8-K filing — Merlin, Inc. (MRLN)
Filed: 2026-10-27 AccNo: 0001628280-26-067435 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Stocks · News reference
Merlin, Inc. has scheduled a presentation and Q&A session to review its financial performance for the third quarter ended September 30, 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-10-27 AccNo: 0001628280-26-067435 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TD Cowen analyst Gautam Khanna maintains Merlin (NASDAQ:MRLN) with a Buy and lowers the price target from $8 to $4.